Eurointervention

Papers
(The H4-Index of Eurointervention is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
TAVR under 70: is age just a number?234
International variation in modality and outcomes of left main revascularisation: does it really matter?128
Double-tap to treat paravalvular leak in high-risk annuli106
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity93
In search of the origin of the acronym TAVI83
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis77
Transcatheter left ventriculoplasty77
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry69
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s63
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis60
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement60
Recanalisation of coronary chronic total occlusions57
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study52
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure50
Defer-based non-stenting: a promising approach for STEMI49
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection48
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve47
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study46
Hybrid coronary revascularisation: the best or the worst of both worlds?45
The “road travelled”: reflections on the transformation of information exchange in a digital age42
One-month DAPT after acute coronary syndrome: too short or not too short?41
   Atrial fibrillation and acute coronary syndrome 41
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document41
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation40
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarc40
Redo transcatheter mitral valve replacement in mitral annular calcification39
A novel robotic radiation shielding device for interventional cardiology procedures37
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes36
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD33
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement33
Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial33
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial33
Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons33
0.029764890670776